15.97

0.77% 0.3871

Personalis Inc (PSNL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$15.58

Aprire:

$15.995

Volume 24 ore:

1.94M

Relative Volume:

0.58

Capitalizzazione di mercato:

$1.68B

Reddito:

$64.52M

Utile/perdita netta:

$-95.55M

Rapporto P/E:

-15.70

EPS:

-1.0169

Flusso di cassa netto:

$-84.65M

1 W Prestazione:

+11.58%

1M Prestazione:

+61.03%

6M Prestazione:

+58.75%

1 anno Prestazione:

+142.28%

Intervallo 1D:

$15.56

$16.39

Intervallo di 1 settimana:

$13.52

$16.39

Portata 52W:

$3.84

$16.39

Personalis Inc Stock (PSNL) Company Profile

Nome

Personalis Inc

Settore

Healthcare (1090)

Industria

Diagnostics & Research (49)

Telefono

650-752-1300

Indirizzo

6600 DUMBARTON CIRCLE, FREMONT, CA

Dipendente

260

Cinguettio

@PersonalisInc

Prossima data di guadagno

2026-08-04

Ultimi documenti SEC

PSNL's Discussions on Twitter

Compare PSNL vs TMO, DHR, IDXX, A, NTRA

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PSNL Personalis Inc	16.05	1.63B	64.52M	-95.55M	-84.65M	-1.0169
TMO Thermo Fisher Scientific Inc	534.83	201.86B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	203.91	145.10B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	569.64	45.44B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	133.84	38.44B	7.23B	1.41B	1.09B	4.979
NTRA Natera Inc	266.61	38.64B	2.50B	-226.32M	71.51M	-1.6412

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-02	Ripresa	Morgan Stanley	Equal-Weight
2025-05-15	Iniziato	Guggenheim	Buy
2025-03-17	Iniziato	Craig Hallum	Buy
2023-02-06	Aggiornamento	Needham	Hold → Buy
2022-01-07	Aggiornamento	BofA Securities	Neutral → Buy
2021-11-05	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-11-03	Downgrade	Needham	Buy → Hold
2021-10-15	Ripresa	Cowen	Outperform
2021-09-20	Reiterato	Needham	Buy
2021-05-06	Aggiornamento	Oppenheimer	Perform → Outperform
2021-01-28	Iniziato	Truist	Buy
2021-01-04	Downgrade	BofA Securities	Buy → Neutral
2020-11-12	Reiterato	Needham	Buy
2020-11-06	Downgrade	Oppenheimer	Outperform → Perform
2020-10-19	Iniziato	Citigroup	Buy
2020-10-08	Iniziato	BTIG Research	Buy
2020-08-27	Iniziato	H.C. Wainwright	Buy
2020-08-18	Iniziato	Needham	Buy
2019-09-26	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-07-15	Iniziato	BofA/Merrill	Neutral
2019-07-15	Iniziato	Cowen	Outperform
2019-07-15	Iniziato	Morgan Stanley	Overweight
2019-07-15	Iniziato	Oppenheimer	Outperform

Mostra tutto

Personalis Inc Borsa (PSNL) Ultime notizie

07:43 AM

Needham raises Personalis stock price target on takeover interest By Investing.com - Investing.com Canada

07:43 AM

Jul 16, 2026

Why Is PSNL Stock Up 5% After-Hours? - Yahoo Finance

Jul 16, 2026

Personalis (PSNL) Recovers After Sale Speculation - GuruFocus

Jul 16, 2026

Jul 15, 2026

TD Cowen Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $18 - Moomoo

Jul 15, 2026

Form 4 Personalis Inc For: 15 July By Investing.com - Investing.com Nigeria

Jul 15, 2026

Personalis president and CMO Richard Chen sells $1.5m in stock - Investing.com

Jul 15, 2026

Personalis president and CMO Richard Chen sells $1.5m in stock By Investing.com - Investing.com India

Jul 15, 2026

How UKCA Approval of NeXT Personal Dx Could Reshape Personalis’ (PSNL) Cross‑Border Cancer Trial Role - simplywall.st

Jul 14, 2026

Personalis receives UK regulatory clearance for cancer test - Investing.com

Jul 14, 2026

Personalis (PSNL) Secures UKCA Marking for NeXT Personal Dx Test - GuruFocus

Jul 14, 2026

Cancer Test for Small DNA Traces Can Now Be Used in Great Britain - Stock Titan

Jul 14, 2026

Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test - Stocktwits

Jul 14, 2026

Jul 13, 2026

PSNL Stock Climbs As Morgan Stanley Lifts Price Target - StocksToTrade

Jul 13, 2026